Onsite Tobacco Cessation Treatment for Patients With PAD

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

ACTIVE_NOT_RECRUITING

Clinical Phase

NA

Total Enrollment

15 participants

Study Classification

INTERVENTIONAL

Study Start Date

2022-08-16

Study Completion Date

2024-07-31

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

Tobacco cessation treatment is needed for individuals with peripheral artery disease (PAD) to improve symptoms, lower cardiovascular risk, and prevent amputation. While such treatment is effective, many PAD patients do not receive cessation therapy. Participants will receive nicotine replacement therapy, counseling, and and complete questionnaires. We hypothesize that integrating tobacco cessation services into a dedicated PAD clinic (OU CVI Limb Preservation Clinic) can improve tobacco cessation rates and improve PAD-related health outcomes in this at risk population.

Related Clinical Trials

Explore similar clinical trials based on study characteristics and research focus.

Path2Quit Tobacco Intervention For African Americans

NCT03524482

Smoking Cessation Smoking, Tobacco

COMPLETED NA

Identifying Optimal Smoking Cessation Intervention Components (Cessation)

NCT01116986

Smoking Smoking Cessation Nicotine Dependence

COMPLETED PHASE4

Tobacco Pilot Study for Low Income Smokers

NCT03017092

Tobacco Use Disorder

COMPLETED NA

Incentives for Oklahoma Tobacco Helpline Engagement in Persistent Poverty Counties

NCT05095779

Cigarette Smoking Nicotine Dependence

COMPLETED PHASE2

Increasing Physical Activity as Part of a Smoking Cessation Program

NCT00403312

Smoking Cessation

COMPLETED NA

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Tobacco Cessation Peripheral Artery Disease

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

NA

Intervention Model

SINGLE_GROUP

Primary Study Purpose

TREATMENT

Blinding Strategy

NONE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Standard Care

All participants will receive standard care by the Tobacco Treatment Research Program. This includes nicotine replacement therapy such as patches, gum, or lozenges, counseling by a Tobacco Treatment Specialist, and complete questionnaires.

Group Type OTHER

Tobacco Treatment Research Program Standard Care

Intervention Type BEHAVIORAL

Participants interested in quitting tobacco will be offered standard tobacco cessation care including nicotine replacement therapy and counseling.

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Tobacco Treatment Research Program Standard Care

Participants interested in quitting tobacco will be offered standard tobacco cessation care including nicotine replacement therapy and counseling.

Intervention Type BEHAVIORAL

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Have diagnosed peripheral artery disease
* Tobacco user
* 18 years of age or older
* Willing/able to attend all study visits
* Be able to read, speak, and understand English

Minimum Eligible Age

18 Years

Maximum Eligible Age

100 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

Yes